RDNT Stock Analysis: Buy, Sell, or Hold?
RDNT - RadNet, Inc. Common Stock
$70.10
-0.61 (-0.86%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When RDNT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RDNT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: RDNT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$37.97
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$23.58
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RDNT is currently trading at $70.10, which is considered oversold relative to its 30-day fair value range of $71.04 to $75.68. The stock's valuation (Forward PE: 90.7) is in line with its historical norms (95.6). Remarkably, the market is currently pricing in an annual earnings decline of 1.8% over the next few years. This pessimistic expectation contrasts with the company's recent 75.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, RDNT is in a downtrend. The price is currently testing key support at $69.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RDNT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $91.75 (+29.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RDNT is in a downtrend. The price is currently testing key support at $69.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RDNT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $91.75 (+29.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$71.04 -
$75.68
Company Quality Score
53/100
(HOLD)
Options IV Signal
32th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
Protect Your Profits
Holding RDNT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 32th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.8% below Wall St target ($91.75)
Fair Price Analysis
30-Day Fair Range
$71.04 -
$75.68
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$5.40
(7.7%)
Support & Resistance Levels
Support Level
$69.40
Resistance Level
$75.01
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
90.65
Wall Street Target
$91.75
(+29.8%)
Revenue Growth (YoY)
13.4%
Earnings Growth (YoY)
75.0%
Profit Margin
-0.6%
Valuation Discount vs History
-1.8% cheaper
PE vs Historical
90.7 vs 95.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.8%
(market-implied from PE analysis)
1-Year Target
$69.44
(-2%)
2-Year Target
$68.19
(-4%)
3-Year Target
$66.96
(-5%)
3-Yr Target (if PE normalizes)
(PE: 91→96)
$70.61
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 90.7, Growth: 106.8%)
$238.65
(+238%)
Base:
(SPY PE: 22.3, Growth: 106.8%)
$58.70
(-17%)
Bear:
(PE: 19.0, Growth: 106.8%)
$49.90
(-29%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 90.7 to 95.6
Stabilization Target:
$74.57
(+5.5%)
PE Expansion Potential:
+5.5%
Last updated: January 30, 2026 7:34 PM ET
Data refreshes hourly during market hours. Next update: 8:34 PM
Data refreshes hourly during market hours. Next update: 8:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RDNT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark Stolper
SELL
35000 shares
2025-09-16
Cornelis Wesdorp
SELL
500 shares
2025-09-11
Norman R Hames
SELL
10000 shares
2025-09-10
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced RDNT Option Strategies
Professional options setups generated by AI based on today's RDNT price and gamma walls.
